TerSera Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Illinois, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
520 Lake Cook Rd Ste 500, Deerfield, Ill...Phone Number
(888) 600-8116Website
www.tersera.comRevenue
$20.1 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About TerSera Therapeutics
TerSera is a biopharmaceutical company dedicated to developing innovative therapies that address unmet health needs. They focus on patient-first solutions, leveraging their expertise to provide unique therapeutics and comprehensive support services. The company aims to deliver meaningful outcomes for patients while building partnerships with providers and customers. TerSera is committed to ensuring that their cornerstones of care reach those who need them most.Explore more
TerSera Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TerSera Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on TerSera Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if TerSera Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at TerSera Therapeutics
Check if TerSera Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once TerSera Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when TerSera Therapeutics launches new products
TerSera Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if TerSera Therapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at TerSera Therapeutics
Find more new buyers
Compare Similar Companies to TerSera Therapeutics
Compare insights from companies similar to TerSera Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
TerSera Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
TerSera Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about TerSera Therapeutics.
TerSera Therapeutics Tech Stack
A closer look at the technologies used by TerSera Therapeutics
See more technologies
Most Recent Scoops
Person-Based
Open Position
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Promotion
Executive Move
Executive Moves, Promotion
TerSera Therapeutics News & Media
TerSera® Presents New Real-World Evidence on Treatment Outcomes of Goserelin (ZOLADEX®) in Women with Breast Cancer at the 2024 San Antonio Breast Cancer Symposium
DEERFIELD, Ill.--(BUSINESS WIRE)--TerSera Therapeutics LLC announced the presentation of new real-world analyses on the use of goserelin 3.6 mg and goserelin 10.8 mg in premenopausal women with breast cancer. These data were presented in a poster session at the 2024 San Antonio Breast Cancer Symposium, held December 10-13 in San Antonio, TX.1 A copy of the poster is available here. This was a retrospective, observational, non-inferiority study using structured, de-identified, patient-level dataMacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®
ROCKVILLE, Md. & DEERFIELD, Ill.--(BUSINESS WIRE)--MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, and TerSera Therapeutics LLC, a privately-held biopharmaceutical company with a focus in oncology and non-opioid pain management, announced today that they have entered into an agreement in which TerSera will acquire global rights to MARGENZA® (marTerSera® Presents Real-World Evidence on Treatment Patterns of Goserelin (ZOLADEX®) in Women with Breast Cancer at the 2024 American Society of Clinical Oncology (ASCO) Quality Care Symposium
DEERFIELD, Ill.--(BUSINESS WIRE)--TerSera Therapeutics LLC announced today the presentation of new real-world analyses on the treatment patterns of goserelin in women with breast cancer. The data were presented in a poster session at the 2024 American Society of Clinical Oncology (ASCO) Quality Care Symposium, held September 27th and 28th in San Francisco, CA.1 A copy of the poster is available here. The goal of this study was to demonstrate the characteristics of US patients withTersera Therapeutics LLC Announces That the 2024 Polyanalgesic Consensus Conference (PACC) Guidelines Issued Updated Guidance for Administering PRIALT
DEERFIELD, Ill.--(BUSINESS WIRE)--TerSera Therapeutics LLC announced today that the 2024 Polyanalgesic Consensus Conference (PACC) guidelines reinforce the role of non-opiate PRIALT in treating severe chronic pain. The 2024 PACC guidelines build upon prior iterations. This includes the 2016 PACC guidelines which recommend PRIALT as a first line option for neuropathic (chronic pain that occur when a health condition affects the nerves that send sensations to the brain) and nociceptive pain (pain
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TerSera Therapeutics
Sign Up For FreeTo access detailed company insights
TerSera is a biopharmaceutical company dedicated to developing innovative therapies that address unmet health needs. They focus on patient-first solutions, leveraging their expertise to provide unique therapeutics and comprehensive support services. The company aims to deliver meaningful outcomes for patients while building partnerships with provid... Read More
